Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant ...

Pathos AI has raised $237 million in Series E financing at a post-money valuation of approximately $3 billion to expand its agentic AI drug development platform and advance a growing portfolio of ...

Microsoft and Carnegie Mellon launch PRAISE, an AI training program that helps junior software engineers develop practical ...

ChatGPT maker OpenAI is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite of products.

On-device AI chip startup Mobilint was named lead researcher for South Korea's $606M K-On-Device program, tasked with ...

These questions over whether AI belongs in the classroom is so polarizing that we cannot put this burden solely on the ...

As artificial intelligence (AI) permeates more fields and applications, organizations may find that it proves difficult to wield without the right knowledge and skill set. That’s why software ...

OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc. Orchestra builds ...

Rocket One Inc. ("Rocket One" or the "Company") today announced a sponsored research agreement with Virginia Commonwealth University ("VCU") to develop and demonstrate magnetic computing devices ...

Forbes contributors publish independent expert analyses and insights. Nirit Cohen covers the Future of Work, bridging trends with solutions. This voice experience is generated by AI. Learn more. This ...

Forbes contributors publish independent expert analyses and insights. Rachel Wells is a writer who covers leadership, AI, and upskilling. This voice experience is generated by AI. Learn more. This ...

We’ve seen them in previews, betas, and initial releases, but in 2026 these AI features will be in every major CAD program. Happy New Year! This is Engineering Paper, a weekly news column bringing you ...